Pharma Veterans

Opioid Crisis and Pharma Industry – Part 5 – Asrar Qureshi’s Blog Post #725 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #725 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Mart Production Photo Credit: Google Images This series of blogposts is based on multiple sources, links to some of which appear at the end. We now look at the factors other than those associated with the pharma companies working. Individual physicians’ approach to the concept of pain relief determines the prescribing habits. While some physicians advise patients to learn to bear a certain degree of pain, the others believe that pain relief must be provided by all means and that the patient must not suffer unnecessarily. In the US, chronic pain was mostly

Opioid Crisis and Pharma Industry – Part 4 – Asrar Qureshi’s Blog Post #724 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #724 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Google Images Photo Credit: Tawfiqu Barbhuiya This series of blogposts is based on multiple sources, links to some of which appear at the end. Three pharmaceutical companies and their involvement has been discussed in detail already. However, such instances are complex matters. Lot of work was done to understand commercial, social, ecological, legal, and policy matters which contributed to the spread of this epidemic. We shall briefly look at these points to strengthen our understanding. Our situation in Pakistan is not much different. We do not have oxyc

Opioid Crisis and Pharma Industry – Part 3 – Asrar Qureshi’s Blog Post #723 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #722 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. This series of blogposts is based on multiple sources, links to some of which appear at the end. Johnson & Johnson is the third company which is implicated in the opioid crisis directly. Their story is by far the most damning in the entire cycle of crisis. In 1980s, J&J needed a reliable supply of opium for a popular product, Tylenol with Codeine. Having the reach of a multinational, they found and acquired a business in Tasmania, Australia, which grew and processed poppies. They grew the business further, and even developed a new strain of poppy called Norman

Opioid Crisis and Pharma Industry – Part 2 – Asrar Qureshi’s Blog Post #722 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #722 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Google Images Photo Credit: Google Images This series of blogposts is based on multiple sources, links to some of which appear at the end. Mallinckrodt plc is an American-Irish company which manufactured semi-synthetic opioid drugs like hydrocodone, hydromorphone, and oxycodone. Between 2006 and 2014, Mallinckrodt accounted for 27% of opioid market compared to 18% of Purdue Pharma. The investigations show that Mallinckrodt, the largest manufacturer of opioids in the US had been able to cultivate hundreds of loyal prescribers, thanks to its aggressive mark

Opioid Crisis and Pharma Industry – Part 1 – Asrar Qureshi’s Blog Post #721 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #721 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Google Images Photo Credit: Google Images Photo Credit: Google Images This series of blogposts is based on multiple sources, links of some of which appear at the end. The Opioid Crisis emerged out of the opioid epidemic which started getting noticed in the US in the early 2010s. The magnitude of problem was so big that the US Department and of Health and Human Sciences – DHSS soon declared it to be a Public Health Emergency, and the entire machinery got active. Since then, there have been numerous lawsuits against the main companies; most have been decide

Product Management is Dead; Long Live Product Management – Last Part – Asrar Qureshi’s Blog Post #720 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #720 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Canva Studio Photo Credit: Christina Morillo Photo Credit: Marcus Aurelius These articles took some insights and the title from INSEAD articles by Ayman Jawhar whose links appear at the end. The original articles are not about pharmaceuticals. As mentioned in the previous post, we shall see the possible solutions. Following are the suggestions. Couple of context setting points. I joined Twitter quite early and I post links to my blogs and vlogs, but not much else. I view it every day however, and get many news from there. A recen

Product Management is Dead; Long Live Product Management – Part 5 – Asrar Qureshi’s Blog Post #719 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #719 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. These articles take some insights and the title from INSEAD articles by Ayman Jawhar whose links appear at the end. The original articles are not about pharmaceuticals. Photo Credit: Alena Darmel Photo Credit: Eva Bronzini Tools and Processes The fourth (last) component of culture is the nuts and bolts of the system. Developed corporates have elaborates processes which are designed to facilitate smooth flow of work. The hierarchies are defined, approval processes are in place, and things are expected to move in an orderly manner. Every organizati

Product Management is Dead; Long Live Product Management – Part 4 – Asrar Qureshi’s Blog Post #718 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #718 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Mikael Blomkvist Photo Credit: Vlada Karpovich These articles take some insights and the title from INSEAD articles by Ayman Jawhar whose links appear at the end. The original articles are not about pharmaceuticals. Product Management is considered a given in pharmaceutical companies, or is it? Majority of the 700 odd pharma companies operating in Pakistan do not have a product manager. They are doing business all the same, in fact, some are doing very big business. Then what is the difference that a product manager brings, or can b

Product Management is Dead; Long Live Product Management – Part 3 – Asrar Qureshi’s Blog Post #717 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #717 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Anna Shvets Photo Credit: Antoni Shkraba These articles take some insights and the title from INSEAD articles by Ayman Jawahar whose links appear at the end. The original articles are not about pharmaceuticals. The second argument from Ayman Jawahar is that product management is not a role.  [Quote] Decouple product management from outdated organizational theories, and stop thinking about it as a role – instead, think of it as a culture. [Unquote] Product managers have a defined role in pharmaceutical industry, and they are supposed

Product Management is Dead; Long Live Product Management – Part 2 – Asrar Qureshi’s Blog Post #716 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #716 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Karolina Grabowska Photo Credit: Ketut Subiyanto These articles take some insights and the title from INSEAD articles by Ayman Jawahar whose links appear at the end. The original articles are not about pharmaceuticals. Ayman Jawahar argues that the ‘perfect combination of skills like business acumen, market orientation, technical skills, and soft skills’ to make a great product manager are no more perfect. He says that we need to understand and redefine the role of product manager from a more meaningful, tasteful, and human-centered